Arbutus Biopharma Corporation ABUS Components
Components at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's components.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's components?
- Arbutus Biopharma Corporation (ABUS) reported components of 22 in Q1 2026.
- How has Arbutus Biopharma Corporation's components changed year-over-year?
- Arbutus Biopharma Corporation's components increased by 57.1% year-over-year, from 14 to 22.
- What is the long-term trend for Arbutus Biopharma Corporation's components?
- Over 3 years (2022 to 2025), Arbutus Biopharma Corporation's components has grown at a -100.0% compound annual growth rate (CAGR), from 53 to 0.
- What does components mean?
- This represents a granular breakdown or specific sub-category of a larger financial statement line item. It is used to provide transparency into the composition of complex balance sheet or income statement accounts. Investors analyze these components to understand the underlying drivers of specific financial performance metrics.